戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1            TM4 mutants were not sensitive to equilibrative (12 mM) sodium concentrations, thereby rul
2 curs primarily via broad-specificity, es (e, equilibrative; 5, sensitive to NBMPR inhibition) transpo
3      Several transport activities, including equilibrative and concentrative mechanisms, have been id
4                                              Equilibrative cation-chloride cotransporters (CCCs) move
5 suggested that this acceleration may involve equilibrative (ENT) and concentrative (CNT) nucleoside t
6                                   Simulating equilibrative glucose inflow via the narrow external ori
7                                  The class 1 equilibrative glucose transporters GLUT1 and GLUT4 are s
8                      Activity assessments at equilibrative [Na(+)] revealed numerous Na(+)-sensitive
9            The protein encoded by SLC43A3_1 [equilibrative nucleobase transporter 1 (ENBT1)] has rece
10 of solute carrier family 43 A3 (SLC43A3), an equilibrative nucleobase transporter, was identified as
11 kly inhibited by the classical inhibitors of equilibrative nucleoside transport, dipyridamole, dilaze
12  the first to predict drug interactions with equilibrative nucleoside transporter (ENT) 1 and ENT2 us
13 rter (CNT) blocker phloridzin but not by the equilibrative nucleoside transporter (ENT) blocker dipyr
14 while requiring intracellular uptake via the equilibrative nucleoside transporter (ENT) ENT1 or the c
15 s a newly cloned transporter assigned to the equilibrative nucleoside transporter (ENT) family (SLC29
16                          Transporters of the equilibrative nucleoside transporter (ENT) family promot
17 de Transporter 1 (PfENT1) is a member of the equilibrative nucleoside transporter (ENT) gene family.
18 cause lung injury via adenosine receptors or equilibrative nucleoside transporter (ENT)-dependent int
19                   They import purines via an equilibrative nucleoside transporter (ENT).
20        Here, we show that the absence of the equilibrative nucleoside transporter (ENT1) in human red
21 anol-sensitive adenosine transporter, type 1 equilibrative nucleoside transporter (ENT1), drink more
22 the nitrobenzylthioinosine (NBMPR)-sensitive equilibrative nucleoside transporter (ENT1), incubation
23 adenosine signaling by inhibiting the type 1 equilibrative nucleoside transporter (ENT1), whereas chr
24 ng to a novel isoform of the NBMPR-sensitive equilibrative nucleoside transporter (ENT1).
25 or DNA and correlating its uptake with human equilibrative nucleoside transporter (hENT1) levels, str
26                                    The human equilibrative nucleoside transporter (hENT1) protein tra
27 s thymidine kinase gene (hsv-tk) and a human equilibrative nucleoside transporter (hENT1).
28                                      The rat equilibrative nucleoside transporter (rENT1) was reveale
29                                  Erythrocyte equilibrative nucleoside transporter 1 (eENT1) levels ar
30 s following uptake into activated T cells by equilibrative nucleoside transporter 1 (ENT1) and inhibi
31                      They import purines via equilibrative nucleoside transporter 1 (ENT1) homologs.
32 s a consequence of ticagrelor inhibiting the equilibrative nucleoside transporter 1 (ENT1) on platele
33                            Overexpression of equilibrative nucleoside transporter 1 (ENT1) or concent
34 ecently, a variant of adenosine transporter, equilibrative nucleoside transporter 1 (ENT1), was assoc
35                     However, the role of the equilibrative nucleoside transporter 1 (ENT1), which is
36 s RBV uptake by preventing the expression of equilibrative nucleoside transporter 1 (ENT1).
37                         Mechanistically, the equilibrative nucleoside transporter 1 (ENT1, SLC29A1) r
38 iation in the last extracellular loop of the equilibrative nucleoside transporter 1 (ENT1; also calle
39    Inhibitor and substrate interactions with equilibrative nucleoside transporter 1 (ENT1; SLC29A1) a
40                      We identified the human equilibrative nucleoside transporter 1 (hENT1) as the mo
41                                    The human equilibrative nucleoside transporter 1 (hENT1) is an imp
42      We have previously shown that the human equilibrative nucleoside transporter 1 (hENT1) is expres
43 e whether the nucleoside transporters, human equilibrative nucleoside transporter 1 (hENT1) or human
44 nomolar concentrations specifically to human equilibrative nucleoside transporter 1 (hENT1) produced
45 H-Thymidine transport was dominated by human equilibrative nucleoside transporter 1 (hENT1) under bot
46                                    The human equilibrative nucleoside transporter 1 (hENT1), a member
47 toxicity include the activities of the human equilibrative nucleoside transporter 1 (hENT1), deoxycyt
48                      The expression of human equilibrative nucleoside transporter 1 (hENT1), thymidin
49  cells expressing thymidine kinase and human equilibrative nucleoside transporter 1 (hENT1).
50                    The Plasmodium falciparum Equilibrative Nucleoside Transporter 1 (PfENT1) is a mem
51 . falciparum, the most virulent species, the equilibrative nucleoside transporter 1 (PfENT1) represen
52 thase (TYMS), thymidine kinase 1 (TK-1), and equilibrative nucleoside transporter 1 (SLC29A1) in HCC
53 specific and FKBP-dependent inhibitor of the equilibrative nucleoside transporter 1 and is efficaciou
54           CBD inhibited adenosine uptake via equilibrative nucleoside transporter 1 and synergistical
55 inding studies confirm that CBD binds to the equilibrative nucleoside transporter 1 with a Ki < 250 n
56 enzymes (connexin43, connexin37, pannexin-1, equilibrative nucleoside transporter 1, CD39, CD73, ecto
57 g an astrocytic adenosine transporter, ENT1 (equilibrative nucleoside transporter 1; Slc29a1), show n
58 eling and experimental studies revealed that equilibrative nucleoside transporter 2 (ENT2), but not E
59   (3)H-FMAU transport was dominated by human equilibrative nucleoside transporter 2.
60         Here, we found that mice lacking the equilibrative nucleoside transporter 3 (ENT3) developed
61                           Mutations in human equilibrative nucleoside transporter 3 (ENT3) encoded by
62                     Mutations exclusively in equilibrative nucleoside transporter 3 (ENT3), the only
63 mutations in SLC29A3, encoding the lysosomal equilibrative nucleoside transporter 3 (ENT3).
64 mercaptopurine riboside (NBMPR)-insensitive, equilibrative nucleoside transporter ei by functional co
65 o the recently cloned human NBMPR-sensitive, equilibrative nucleoside transporter ENT1 and thus was d
66 ble to penetrate into cells deficient in the equilibrative nucleoside transporter ENT2, and reconstit
67 de membrane transport: the concentrative and equilibrative nucleoside transporter families.
68 identifies three transport mechanisms of the equilibrative nucleoside transporter family by which nuc
69  the first demonstration that members of the equilibrative nucleoside transporter family can be elect
70                             Permeases of the equilibrative nucleoside transporter family mediate the
71         Previous studies have implicated the equilibrative nucleoside transporter family member equil
72                   Permeases belonging to the equilibrative nucleoside transporter family promote upta
73          The first mammalian examples of the equilibrative nucleoside transporter family to be charac
74  being imported into cells by members of the equilibrative nucleoside transporter family, NR is predo
75                     LdNT2 is a member of the equilibrative nucleoside transporter family, which posse
76 s that is homologous to other members of the equilibrative nucleoside transporter family.
77 substantial homology to other members of the equilibrative nucleoside transporter family.
78 topology similar to members of the mammalian equilibrative nucleoside transporter family.
79 ituted gate operates in other members of the equilibrative nucleoside transporter family.
80        PfNT2 is, like PfNT1, a member of the equilibrative nucleoside transporter family.
81  but exhibits low homology to members of the equilibrative nucleoside transporter family.
82 ishmania donovani express two members of the equilibrative nucleoside transporter family; LdNT1 encod
83 exposure of SKOV-3 cells to dipyridamole, an equilibrative nucleoside transporter inhibitor; APCP, a
84                                          The equilibrative nucleoside transporter subtype 1 (ENT1) pl
85                                   ENT1 is an equilibrative nucleoside transporter that enables trans-
86 onstrate that Fun26, a homolog of human ENT (equilibrative nucleoside transporter), localizes to the
87 on of the adenosine transporter ENT1 (type 1 equilibrative nucleoside transporter), which provides pr
88                                    The human equilibrative nucleoside transporter, hENT1, which is se
89 hich inhibits transport of adenosine through equilibrative nucleoside transporter, raised the measure
90 brative nucleoside transporter family member equilibrative nucleoside transporter-1 (ENT1) in the reg
91 investigated the effect on tumor immunity of equilibrative nucleoside transporter-1 (ENT1), the major
92 lism by potently and directly inhibiting the equilibrative nucleoside transporter-1 (ENT1).
93                      Low expression of human equilibrative nucleoside transporter-1 (hENT1) may resul
94 raC-8C cells that are deficient in the human equilibrative nucleoside transporter-1, the IC(50) of Ge
95 recently cloned dipyridamole-sensitive human equilibrative nucleoside transporter.
96 press both a nucleoside kinase as well as an equilibrative nucleoside transporter.
97 enosine kinase, adenosine deaminase, and the equilibrative nucleoside transporter: mature receptors w
98                                              Equilibrative nucleoside transporters (ENTs) 1 and 2 fac
99 entrative nucleoside transporters (CNTs) and equilibrative nucleoside transporters (ENTs) are importa
100                                              Equilibrative nucleoside transporters (ENTs) are polytop
101                                              Equilibrative nucleoside transporters (ENTs) are present
102              Consistent with the notion that equilibrative nucleoside transporters (ENTs) terminate a
103                                              Equilibrative nucleoside transporters (ENTs) translocate
104 ards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothe
105 ignaling is terminated by its uptake through equilibrative nucleoside transporters (ENTs).
106 e occurred by translocation of adenosine via equilibrative nucleoside transporters (ENTs).
107  the hypothesis that human concentrative and equilibrative nucleoside transporters (hCNT1 and hENT1)
108 ntine) is a clinically used vasodilator with equilibrative nucleoside transporters 1 and 2 (ENT1 and
109       We stably transfected the cloned human equilibrative nucleoside transporters 1 and 2 (hENT1 and
110 ed remdesivir and EIDD-1931 as substrates of equilibrative nucleoside transporters 1 and 2.
111 ntracellular uptake depends predominantly on equilibrative nucleoside transporters after conversion o
112                                              Equilibrative nucleoside transporters are a unique famil
113 studies demonstrate that the NBMPR-sensitive equilibrative nucleoside transporters are novel and unex
114 sine A2B receptor agonists and inhibition of equilibrative nucleoside transporters by dipyridamole ma
115                                              Equilibrative nucleoside transporters encompass two cons
116 1 receptors but required adenosine uptake by equilibrative nucleoside transporters followed by its (i
117                                              Equilibrative nucleoside transporters of the SLC29 famil
118                                              Equilibrative nucleoside transporters play essential rol
119 permease is related in sequence to mammalian equilibrative nucleoside transporters.
120 ine, but not other deoxynucleosides, through equilibrative nucleoside transporters.
121 osine reuptake into proximal tubule cells by equilibrative nucleotide transporter 1, which can be inh
122 creted primarily via a decynium-22-sensitive equilibrative plasma membrane monoamine transporter inst
123  translocated rapidly into the cells by both equilibrative-sensitive and -insensitive nucleoside tran
124                              GLUT1-catalyzed equilibrative sugar transport across the mammalian blood
125                                     Blocking equilibrative transport using the inhibitor nitrobenzylm
126 ar uptake due to low expression of the human equilibrative transporter (hENT1).
127 s within TMD 3-6, which are conserved across equilibrative transporter sequences from several species

 
Page Top